Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
New synthetic inhibitors of microtubule depolymerizationU Klar, H Graf, O Schenk, et al.Prostaglandins|August 1, 1995
Novel prostanoid thromboxane A2 agonistsK D Joachim, U Klar, A Pletsch, et al.Cancer Research|August 2, 2001
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitorsR B Lichtner, A Menrad, A Sommer, et al.Eicosanoids|January 1, 1990
Development, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprostM Hildebrand, B Nieuweboer, H Biere, et al.Proceedings of the National Academy of Sciences of the United States of America|September 20, 2001
Subcellular distribution of epothilones in human tumor cellsR B Lichtner, A Rotgeri, T Bunte, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 25, 2010
The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivoA Strube, M I Suominen, J P Rissanen, et al.Cancers|June 5, 2020
Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid CulturesLukas M Braun, Simon Lagies, Rhena F U Klar, et al.Journal of Cell Science|December 2, 2022
STAT3 signaling induced by the IL-6 family of cytokines modulates angiogenesisJulian Rapp, Malte Jung, Rhena F U Klar, et al.Scientific Reports|April 6, 2021
Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinomaMarie-Claire Rittmann, Saskia Hussung, Lukas M Braun, et al.BMC Cancer|January 12, 2021
Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancerSaskia Hussung, Dilara Akhoundova, Julian Hipp, et al.Pageof 2